[go: up one dir, main page]

WO2017093150A1 - Appareil de surveillance et procédé de surveillance pour déterminer des informations de signes vitaux d'un sujet - Google Patents

Appareil de surveillance et procédé de surveillance pour déterminer des informations de signes vitaux d'un sujet Download PDF

Info

Publication number
WO2017093150A1
WO2017093150A1 PCT/EP2016/078921 EP2016078921W WO2017093150A1 WO 2017093150 A1 WO2017093150 A1 WO 2017093150A1 EP 2016078921 W EP2016078921 W EP 2016078921W WO 2017093150 A1 WO2017093150 A1 WO 2017093150A1
Authority
WO
WIPO (PCT)
Prior art keywords
signal
ultrasound
basis
periodical
transducer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2016/078921
Other languages
English (en)
Inventor
Ronaldus Maria Aarts
Rick BEZEMER
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Koninklijke Philips NV
Original Assignee
Koninklijke Philips NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Koninklijke Philips NV filed Critical Koninklijke Philips NV
Publication of WO2017093150A1 publication Critical patent/WO2017093150A1/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
    • A61B5/026—Measuring blood flow
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
    • A61B5/026—Measuring blood flow
    • A61B5/029—Measuring blood output from the heart, e.g. minute volume
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7221—Determining signal validity, reliability or quality
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
    • A61B8/02—Measuring pulse or heart rate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
    • A61B8/06—Measuring blood flow
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
    • A61B8/42—Details of probe positioning or probe attachment to the patient
    • A61B8/4209—Details of probe positioning or probe attachment to the patient by using holders, e.g. positioning frames
    • A61B8/4236—Details of probe positioning or probe attachment to the patient by using holders, e.g. positioning frames characterised by adhesive patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
    • A61B5/14551—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using optical sensors, e.g. spectral photometrical oximeters for measuring blood gases

Definitions

  • the present invention relates to a monitoring apparatus for monitoring vital sign information of a subject, in particular for hemodynamic monitoring of a subject.
  • the present invention further relates to a monitoring method for monitoring vital sign information of a subject and to a computer program product comprising computer readable program code means embodied therein for causing a computer to carry out the steps of the monitoring method for monitoring the vital sign information of the subject.
  • Hemodynamic monitoring to determine hypervolemia or hypovolemia is important measurement of vital signs of a patient in the intensive care and during major surgeries.
  • the functional hemodynamic monitoring can be defined as the assessment of the dynamic interactions of hemodynamic variables in response to a defined perturbation.
  • the hemodynamic monitoring can be performed invasively e.g. by an arterial line or indirect by means of pulse signal contour analysis.
  • the hemodynamic monitoring and the monitoring of the patient's blood volume status is performed by measuring a beat-to-beat stroke volume variation or by measuring a pulse pressure variation, wherein hand-held ultrasound probes are used to measure the respective signal e.g. at the carotid artery and using Doppler measurements.
  • a corresponding method for measuring a blood volume based on esophageal Doppler measurements is e.g. known from "Monitoring of respiratory variations of aortic blood flow velocity using esophageal Doppler" in Intensive Care Med, 2004, vol. 30, pp. 1182 - 1187.
  • a monitoring apparatus for monitoring vital sign information of a subject comprising:
  • a transducer for emitting and receiving ultrasound waves, light waves, or electromagnetic waves and for providing a variable measurement signal on the basis of the ultrasound waves, the light waves, or the electromagnetic waves received from the subject, a processing unit for determining a first periodical signal component of the variable measurement signal and a second periodical signal component of the variable measurement signal, wherein the processing unit is adapted to determine the vital sign information on the basis of the first periodical signal component and to determine a signal quality of the variable measurement signal on the basis of the second periodical signal component.
  • a monitoring method for monitoring vital sign information of a subject comprising the steps of:
  • determining a first periodical signal component of the variable measurement signal and a second periodical signal component of the variable measurement signal and determining the vital sign information on the basis of the first periodical signal component and determining a signal quality of the variable measurement signal on the basis of the second periodical signal component.
  • a computer program product comprising computer readable program code means embodied therein is provided for causing a computer to carry out the steps of the monitoring method according to the present invention, when said computer program is carried out on a suitable computer or processor.
  • the present invention is based on the idea to determine the vital sign information on the basis of a variable measurement signal, i.e. a variable ultrasound signal, a variable light signal, or a variable electromagnetic wave signal, which is determined by means of an ultrasound transducer or a light emitter and light detector or an electromagnetic wave emitter and detector at a volume of the subject, wherein a first periodical signal component of the variable measurement signal is extracted from the measurement signal and utilized to determine the vital sign information and wherein a second periodical signal component is derived from the ultrasound signal, the light signal or the electromagnetic wave signal and utilized to determine a signal quality of the variable measurement signal.
  • a variable measurement signal i.e. a variable ultrasound signal, a variable light signal, or a variable electromagnetic wave signal
  • the vital sign formation which is at least partially a respiration-induced vital sign or corresponds at least partially to a respiration-induced vital sign is determined on the basis of the measurement signal
  • a non-invasive measurement can be provided and since the signal quality is determined on the basis of the second periodical signal component derived from the measurement signal, the respective signal quality and the respective position of the transducer can be determined with high precision so that a reliable monitoring of the vital sign can be provided.
  • the signal quality is not determined on the basis of the signal strength of the received signal itself, but on the basis of the second periodical signal component of the variable measurement signal, the variable measurement signal can be easily distinguished from different vital signals of the subject and the measurement of artefacts and noise can be avoided. Since the signal quality can be determined with high precision on the basis of the second periodical signal component, a simple transducer can be utilized while mismeasurements can be avoided so that the overall technical effort for the monitoring apparatus can be reduced.
  • the present invention provides a monitoring of a vital sign information of a subject with an improved reliability and with a reduced technical effort.
  • the first periodical signal component is an upper modulation component and the second periodical signal component is a lower modulation component of the variable measurement signal. This is a possibility to precisely distinguish the vital sign information detection in the variable measurement signal and the detection of the signal quality with low technical effort.
  • the processing unit is further adapted to determine the vital information on the basis of the first periodical signal component and on the basis of the second periodical signal component. This is a possibility to further improve the preciseness of the detection of the vital sign information of the subject on the basis of the variable measurement signal.
  • the processing unit is further adapted to determine a ratio of the first periodical signal component and the second periodical signal component and to determine the vital sign information on the basis of the ratio of the first periodical signal component and the second periodical signal component. This is a possibility to determine the vital sign information, in particular any hemodynamic signal like a volume status of the subject with low technical effort and to distinguish different levels of the vital sign formation.
  • the processing unit is further adapted to determine an upper amplitude of the variable measurement signal on the basis of the first periodical signal component and a lower amplitude of the variable measurement signal on the basis of the second periodical signal component, and to determine the vital sign information on the basis of a ratio of the upper and the lower amplitude.
  • the transducer is an ultrasound transducer including at least one ultrasound transducer element for emitting and receiving ultrasound waves and for providing a variable ultrasound signal as the variable measurement signal on the basis of the ultrasound waves received from a volume of the subject. This is a possibility to provide an ultrasound measurement with low technical effort.
  • the transducer is a light transducer including at least one light emitter and a light detector for emitting and receiving light waves and for providing the variable measurement signal on the basis of the light waves received from the volume of the subject and detected by the light detector.
  • the light emitter comprises a laser emitter for emitting the light. This is a possibility to detect a photoplethysmography signal from the subject and to determine the vital sign information on the basis of the photoplethysmography signal.
  • the transducer is an electromagnetic transducer including an emitter and a detector for transmitting and receiving electromagnetic waves. This is an alternative possibility to detect the vital sign information with high precision.
  • the vital sign information is a hemodynamic signal of the subject, in particular a blood volume status of the subject. This is a possibility to determine hemodynamics of the subject and to distinguish hypervolemia, normovolemia and
  • hypovolemia non-invasively with reduced effort.
  • the ultrasound transducer is a wide angle continuous wave Doppler ultrasound transducer. This is a possibility to reduce the technical effort for providing the variable ultrasound signal and for monitoring the vital sign information of the subject in general.
  • the ultrasound signal is a blood velocity signal determined in the volume of the subject. This is a possibility to determine the blood volume status or the blood pressure of the subject non-invasively with low technical effort.
  • the ultrasound transducer comprises a single transducer element for emitting and receiving the ultrasound waves.
  • the ultrasound transducer comprises an array of transducer elements and a control unit for controlling the array of transducer elements, wherein the control unit is adapted to steer a field of view of the array of transducer elements towards the volume of interest.
  • control unit is adapted to steer the field of view towards the volume of interest on the basis of the variable ultrasound signal. This is a possibility to steer the field of view towards the largest signal strength of the variable ultrasound signal, so that the preciseness of the monitoring of the vital sign information can be further improved.
  • the ultrasound transducer comprises an array of transducer elements which provide a static electromagnetic beam transmission.
  • the processing unit comprises an analysis unit for analyzing the variable measurement signal and at least two diodes connecting the analysis unit to the transducer for filtering the variable measurement signal received from the transducer. This is a possibility to determine the first periodical signal component and the second periodical signal component of the variable measurement signal.
  • the at least two diodes are disposed anti-parallel to each other.
  • the diodes are connected in parallel to each other having opposite forward directions. This is a possibility to determine the first periodical signal component and the second periodical signal component as positive and negative signal components with low technical effort.
  • the processing unit comprises an offset unit for providing an offset signal to the variable measurement signal. This is a possibility to set a zero point or a zero level of the variable measurement signal to a desired level so that the first periodical signal component and the second periodical signal component can be easily determined as positive and negative signal component of the variable measurement signal.
  • the transducer is coupled to a coupling layer for coupling the transducer to the subject. This is a possibility to connect the transducer to the subject with low technical effort and to precisely determine the variable measurement signal and the corresponding vital sign information continuously.
  • the ultrasound transducer is coupled to the subject by means of an adhesive layer. This is a possibility to attach the ultrasound transducer fixedly to the subject to determine the vital sign information precisely and continuously over a large time period.
  • the ultrasound transducer comprises a string of transducer elements, and wherein the ultrasound signal is selected from a plurality of ultrasound signals received by the transducer elements. This is a possibility to determine one of the transducer elements, which is in the vicinity of a blood vessel to be measured so that the variable ultrasound signal can be determined with low technical effort.
  • the ultrasound signal is selected from the plurality of ultrasound signals received from the transducer elements having the largest signal strength. This is a possibility to select the variable ultrasound signal having the best signal quality so that the vital sign information can be determined precisely with low technical effort.
  • the vital sign information in particular the blood volume status or the blood pressure can be determined on the basis of the first periodical signal component of the variable measurement signal and the signal quality can be determined based on a separate second periodical signal component of the variable measurement signal so that a simple transducer can be utilized while the precision of the determination of the vital sign information can still be achieved.
  • the vital sign information of the subject can be determined with high precision and low technical effort in general.
  • Fig. 1 shows a schematic representation of a monitoring apparatus in use to scan a volume of a patient's body
  • Fig. 2a - c show different timing diagrams of blood velocities and the corresponding airway pressure measured at a vessel of the patient;
  • Fig. 3 shows a schematic flow diagram of a method to determine the vital sign information of the patient
  • Fig. 4 shows a schematic representation of a control unit and a processing unit for determining the vital sign information of the subject on the basis of a variable ultrasound signal
  • Fig. 5 shows a schematic representation of an ultrasound transducer including a string of transducer elements for determining an ultrasound signal of the patient's body.
  • Fig. 1 shows a schematic illustration of a monitoring apparatus generally denoted by 10.
  • the monitoring apparatus 10 is provided for monitoring vital sign information of a subject 12, in particular a patient 12.
  • the monitoring apparatus 10 comprises an ultrasound transducer 14 including one transducer element or a multitude of transducer elements for transmitting and receiving ultrasound waves.
  • the ultrasound transducer 14 is preferably attached to the patient's body by means of an adhesive layer 16 and attached to the skin of the patient's body in the vicinity of a large artery 18 such as the carotid as shown in Fig. 1 or the aorta.
  • the ultrasound transducer 14 is attached to the subject 12 to measure non- invasively a variation of a blood velocity in the artery 18 and to calculate the blood pressure and/or the blood volume status of the subject 12 on the basis of the variation of the blood velocity as described in the following.
  • the ultrasound transducer 14 including the single transducer element is preferably formed as a simple wide-angle continuous-wave Doppler system in order to measure the blood velocity in the artery 18.
  • an ultrasound transducer 14 comprises the multitude of transducer elements which are arranged in a string of transducer elements or in a 2D-transducer array to determine the blood velocity on the basis of a wide-angle continuous-wave Doppler measurement.
  • the transducer elements may be formed as piezoelectric micro-machined ultrasound transducer (PMUT) or as capacitive micro-machined ultrasound transducers (CMUT).
  • the monitoring apparatus 10 further comprises a control unit 20 including a controller 22 and a processing unit 24.
  • the control unit 20 is connected or connectable to the ultrasound transducer 14 by means of a cable connection or by means of a wireless connection, wherein the controller 22 receives a variable ultrasound signal as measurement signals from the ultrasound transducer 14 and controls the ultrasound transducer 14 accordingly.
  • the processing unit 24 receives the variable ultrasound signal from the ultrasound transducer 14 and determines a first periodical signal component of the variable ultrasound signal and a second periodical signal component of the ultrasound signal and determines the vital sign information of the subject 12 on the basis of the first periodical signal component and in particular on the basis of the second periodical signal component as described in the following.
  • the processing unit 24 may further determine a signal quality of the variable ultrasound signal on the basis of the second periodical signal component.
  • the control unit 20 may be connected or connectable to an output device 26, e.g. a display device 26 and may be connected or connectable to an input device 28 which may be connected to the output device 26 or to the control unit 20 in order to control the acquisition of the measurement data.
  • the output device 26 and the input device 28 may be connected to the control unit 20 by means of a cable connection or by means of a wireless connection.
  • the ultrasound transducer 14 is attached to a skin of the subject 12 and formed e.g. as a wearable patch or a sticky plaster which is placed on the top of the skin at the artery 18 as shown in Fig. 1.
  • the ultrasound transducer 14 measures the blood velocity in the artery 18 on the basis of the ultrasound waves received by the ultrasound transducer 14 and the ultrasound transducer 14 provides the corresponding variable ultrasound signal to the processing unit 24.
  • the processing unit 24 determines a first periodical signal component of the variable ultrasound signal as an upper modulation component or an upper amplitude of the variable ultrasound signal and determines the vital sign information, which may be any hemodynamic signal like a blood pressure or a blood volume status of the subject on the basis of the so determined first periodical signal component.
  • the vital sign information may be at least partially a respiration-induced vital sign and corresponds at least partially to the respiration of the subject 12.
  • the processing unit 24 further determines a second periodical signal component as a lower modulation component or a lower amplitude of the variable ultrasound signal and determines a signal quality of the variable ultrasound signal on the basis of this second periodical signal component.
  • the processing unit 24 can determine noise or movement artifacts affecting the whole variable ultrasound signal and can distinguish those noise or artifact signals from the vital sign information and in particular from the onesided hemodynamic modulation of the variable ultrasound signal.
  • the ultrasound transducer 14 can be formed as a simple ultrasound transducer for determining a vital sign information of the subject 12, since the quality of the detected signal is evaluated on the basis of the second periodical signal component. If the measurement of the second periodical signal component shows that the variable ultrasound signal is corrupted or an artifact signal, the measurement of the variable ultrasound signal is ignored and a warning signal may be provided by means of the output device 26 to the user.
  • the control unit 22 is adapted to steer the ultrasound waves automatically towards a volume of the subject, where the variable ultrasound signal is measured having the largest signal strength. This is a possibility to steer the ultrasound waves automatically to the artery 18 and to provide a precise and reliable variable ultrasound signal to the control unit 20.
  • the ultrasound transducer 14 comprises a string of transducer elements which are arranged in a straight line, wherein the string of transducer elements is attached to the subject 12 so that the string of the transducer elements is arranged across to the artery 18.
  • Each of the transducer elements provide a separate variable ultrasound signal and the controller 22 selects the variable ultrasound signal from the transducer elements having the best signal quality and/or the largest signal strength.
  • the processing unit 24 calculates a first ratio of the lower amplitude of the variable ultrasound signal to the average value of the variable ultrasound signal and a second ratio of the upper amplitude to the average of the variable ultrasound signal.
  • the processing unit 24 further determines a ratio between the first and the second ratio, i.e. the upper amplitude modulation and the lower amplitude modulation and determines the volume status or the fluid responsiveness of the patient 12 on the basis of the so determined ratio.
  • the ratio may be evaluated on the basis of a linear or a non-linear function or a look-up table, wherein a low value of the ratio reflects hypovolemia and a high value reflects hypervolemia, i.e. fluid overload.
  • the monitoring apparatus 10 comprises a light source, in particular a laser light source such as a laser speckle or a laser Doppler imaging unit which are sensitive to the movement of the artery 18 and other superficial tissues like organs exposed during surgery.
  • the blood velocity in the artery 18 is measured on the basis of a light signal emitted by the light source and detected by a light detection element and the light detection element provides a variable measurement signal on the basis of the detected light.
  • the variable measurement signal is evaluated identical with the evaluation of the variable ultrasound signal as mentioned above.
  • the detected light may be used for detecting a photoplethysmography (PPG) signal.
  • PPG photoplethysmography
  • the monitoring apparatus 10 comprises a transducer for emitting and receiving electromagnetic waves, wherein the transducer provides a variable measurement signal corresponding to vital sign information of the subject 12 on the basis of the detected electromagnetic waves.
  • the variable measurement signal is evaluated identical with the evaluation of the variable ultrasound signal as mentioned above.
  • the respiration of the subject 12 can be determined separately e.g. by means of a ventilator, an accelerometer or a respiration belt and the respiration signal can be utilized to demodulate the variable measurement signal, i.e. the Doppler signal. This can be advantageous if the variable measurement signal has a reduced signal quality.
  • Fig. 2a-c show timing diagrams of a blood velocity and an airway pressure for three different blood volumes, wherein Fig. 2a shows the respective measurements for hypervolemia, Fig. 2b shows the measurements for normovolemia and Fig. 2c shows the respective diagrams for hypovolemia.
  • the measured blood velocity v which corresponds to the variable ultrasound signal determined by the ultrasound transducer 14 or the light detection device is a periodical signal, which shows an upper amplitude modulation (systolic) and a lower amplitude modulation (diastolic), wherein the upper peaks of the measured blood velocity, i.e. the upper amplitude of the measured blood velocity varies periodically over time.
  • the upper amplitude is a difference between the positive peaks and an average signal component of the ultrasound signal.
  • the modulation of the blood velocity is a respiration induced variation.
  • the amplitude variation of the blood velocity increases from Fig. 2a to Fig. 2c.
  • the signal of the measured blood velocity v shows a lower amplitude modulation, wherein the lower peaks of the blood velocity signal vary periodically.
  • the lower amplitude is a difference between the negative peaks and an average signal component of the ultrasound signal.
  • the lower amplitude variation is low for the different blood volumes and varies slightly from Fig. 2a to Fig. 2c. From the upper amplitude modulation of the blood velocity v, the airway pressure P can be determined as shown in Fig. 2a-c.
  • Fig. 3 shows a schematic flow diagram of a method to determine the vital sign information of the subject 12 and in particular the blood volume status of the subject 12.
  • the monitoring method shown in Fig. 3 is generally denoted by 30.
  • the measured value is in this particular case the blood velocity v but the measured value may be any hemodynamic signal that is modulated by the respiration at one side or at two sides.
  • the method 30 starts with step 32, the detection of the ultrasound, light or electromagnetic waves by means of the ultrasound transducer 14 or the light measurement device or an electromagnetic wave detector and the determining of the variable measurement signal.
  • the variable measurement signal is evaluated at a step 34 and on the basis of the signal strength, the transducer array may be steered to the artery 18 and the measurement of the variable measurement signal is repeated as indicated by the feedback loop shown in Fig. 3.
  • the first periodical signal component is determined as an upper modulation component or an upper amplitude modulation of the variable measurement signal and in step 38 the second periodical signal component is determined as a lower modulation component or a lower amplitude modulation of the variable measurement signal.
  • the first periodical signal component and the second periodical signal component are evaluated at step 40 as mentioned above by determining a ratio between the respective amplitude values.
  • the second periodical signal component is evaluated in order to determine the signal quality of the variable measurement signal and to determine whether the variable
  • the vital sign information of the subject 12 e.g. the blood volume status is determined, wherein the respective measurement is ignored if a corruption of the variable measurement signal has been detected as step 42.
  • a reliable determination of the vital sign information and in particular the blood volume status of the subject 12 can be determined with low technical effort and high precision.
  • the determination of the vital sign information of the subject at step 44 may be calibrated on the basis of a parallel different measurement method of the respective vital sign information e.g. on the basis of an invasive measurement method.
  • the calibration may be performed on different patients in order to determine an appropriate classification of the vital sign information (e.g. the volume status) and stored in a memory device for further measurements.
  • Fig. 4 shows a schematic diagram of the control unit 20.
  • the control unit 20 is connected to the ultrasound transducer 14 or the light detection unit and receives the corresponding variable measurement signal.
  • the control unit 20 comprises a Doppler electronic unit 46, which evaluates the measurement and determines the variable
  • the control unit 20 further comprises an analysis unit 48, which is connected via two diodes 50, 52 to the Doppler electronic unit 46 for filtering the variable measurement signal and for providing the first periodical signal component and the second periodical signal component of the variable measurement signal to the analysis unit 48. Since the first and the second periodical signal components are positive and negative peaks of the variable measurement signal, the diodes 50, 52 which are connected antiparallel to each other can filter the corresponding periodical signal components with low technical effort. The diodes 50, 52 are connected to each other at one side and in opposite forward directions.
  • the analysis unit 48 may be connected via a digital circuit to the Doppler electronic unit 46 for filtering the variable measurement signal and for providing the first periodical signal component and the second periodical signal component of the variable measurement signal to the analysis unit 48.
  • the digital circuit serves as a digital filter e.g. for providing the first periodical signal component and the second periodical signal component to the analysis unit if the signal components are positive or for yielding the ratio of the first and the second periodical signal component.
  • the analysis unit 48 determines a modulation of the upper amplitude and the lower amplitude of the variable measurement signal on the basis of the first and the second periodical signal component and compares the amplitude modulation to the average of the variable ultrasound signal which is also provided by means of a bypass line to the analysis unit 48.
  • the analysis unit 48 may also receive an external reference signal to obtain the blood volume status of the subject 12 on the basis of corresponding functions or look-up tables.
  • the analysis unit 48 provides the vital sign information e.g. the blood volume status as an output signal to the output device 26.
  • FIG. 5 shows an embodiment of the ultrasound transducer 14 comprising a plurality of ultrasound transducers 54, which are arranged in a straight line or a string as shown in Fig. 5.
  • the string of transducer elements 54 is disposed across the artery 18 to be measured, wherein each of the transducer elements 54 provide a separate variable ultrasound signal to the control unit 20 (not shown).
  • the control unit 20 and in particular the controller 22 select one of the variable ultrasound signals received from the ultrasound transducer elements 54 having the highest signal strength to determine the variable ultrasound signal having the best quality and the best placement with respect to the artery 18.
  • the variable ultrasound signal of the plurality of signals received from the transducer elements 54 is selected on the basis of the second periodical signal component determined by the processing unit 24 so that in advance the variable ultrasound signal which is not corrupted by artifacts or noise can be selective.
  • the string of transducer elements 54 can therefore be placed easier with a reduced precision and is also more robust against displacement and movement e.g. of the skin of the subj ect with respect to the artery 18.
  • a computer program may be stored/distributed on a suitable medium, such as an optical storage medium or a solid-state medium supplied together with or as part of other hardware, but may also be distributed in other forms, such as via the Internet or other wired or wireless telecommunication systems.
  • a suitable medium such as an optical storage medium or a solid-state medium supplied together with or as part of other hardware, but may also be distributed in other forms, such as via the Internet or other wired or wireless telecommunication systems.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Surgery (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Physiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Signal Processing (AREA)
  • Artificial Intelligence (AREA)
  • Psychiatry (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)

Abstract

La présente invention concerne un appareil de surveillance (10) pour surveiller les informations de signes vitaux d'un sujet (12). L'appareil de surveillance comprend un transducteur (14) pour émettre et recevoir des ondes ultrasonores, des ondes lumineuses ou des ondes électromagnétiques et pour produire un signal de mesure variable sur la base des ondes ultrasonores, des ondes lumineuses ou des ondes électromagnétiques reçues depuis le sujet. Une unité de traitement (24) est fournie pour analyser le signal de mesure variable pour déterminer une première composante de signal périodique du signal de mesure variable et une deuxième composante de signal périodique du signal de mesure variable, l'unité de traitement étant adaptée pour déterminer les informations de signes vitaux sur la base de la première composante de signal périodique et pour déterminer une qualité de signal du signal de mesure variable sur la base de la deuxième composante de signal périodique.
PCT/EP2016/078921 2015-12-02 2016-11-28 Appareil de surveillance et procédé de surveillance pour déterminer des informations de signes vitaux d'un sujet Ceased WO2017093150A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP15197438 2015-12-02
EP15197438.3 2015-12-02

Publications (1)

Publication Number Publication Date
WO2017093150A1 true WO2017093150A1 (fr) 2017-06-08

Family

ID=54770986

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2016/078921 Ceased WO2017093150A1 (fr) 2015-12-02 2016-11-28 Appareil de surveillance et procédé de surveillance pour déterminer des informations de signes vitaux d'un sujet

Country Status (1)

Country Link
WO (1) WO2017093150A1 (fr)

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3492003A1 (fr) * 2017-12-01 2019-06-05 Samsung Electronics Co., Ltd. Appareil et procédé d'évaluation de la qualité de signaux biologiques
EP3494895A1 (fr) * 2017-12-07 2019-06-12 Koninklijke Philips N.V. Surveillance de patient
CN111818854A (zh) * 2018-02-08 2020-10-23 皇家飞利浦有限公司 监测对象中的血液分布
USD917704S1 (en) 2019-08-16 2021-04-27 Masimo Corporation Patient monitor
USD919094S1 (en) 2019-08-16 2021-05-11 Masimo Corporation Blood pressure device
USD919100S1 (en) 2019-08-16 2021-05-11 Masimo Corporation Holder for a patient monitor
USD921202S1 (en) 2019-08-16 2021-06-01 Masimo Corporation Holder for a blood pressure device
USD927699S1 (en) 2019-10-18 2021-08-10 Masimo Corporation Electrode pad
USD933232S1 (en) 2020-05-11 2021-10-12 Masimo Corporation Blood pressure monitor
US11457872B2 (en) 2017-12-01 2022-10-04 Samsung Electronics Co., Ltd. Bio-signal quality assessment apparatus and bio-signal quality assessment method
US11576582B2 (en) 2015-08-31 2023-02-14 Masimo Corporation Patient-worn wireless physiological sensor
USD979516S1 (en) 2020-05-11 2023-02-28 Masimo Corporation Connector
US11637437B2 (en) 2019-04-17 2023-04-25 Masimo Corporation Charging station for physiological monitoring device
USD985498S1 (en) 2019-08-16 2023-05-09 Masimo Corporation Connector

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130079606A1 (en) * 2011-09-23 2013-03-28 Nellcor Puritan Bennett Ireland Systems and methods for determining respiration information from a photoplethysmograph

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130079606A1 (en) * 2011-09-23 2013-03-28 Nellcor Puritan Bennett Ireland Systems and methods for determining respiration information from a photoplethysmograph

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
"Monitoring of respiratory variations of aortic blood flow velocity using esophageal Doppler", INTENSIVE CARE MED, vol. 30, 2004, pages 1182 - 1187

Cited By (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12150739B2 (en) 2015-08-31 2024-11-26 Masimo Corporation Systems and methods for patient fall detection
US11576582B2 (en) 2015-08-31 2023-02-14 Masimo Corporation Patient-worn wireless physiological sensor
US12133717B2 (en) 2015-08-31 2024-11-05 Masimo Corporation Systems and methods for patient fall detection
US11457872B2 (en) 2017-12-01 2022-10-04 Samsung Electronics Co., Ltd. Bio-signal quality assessment apparatus and bio-signal quality assessment method
US11911184B2 (en) 2017-12-01 2024-02-27 Samsung Electronics Co., Ltd. Bio-signal quality assessment apparatus and bio-signal quality assessment method
EP3492003A1 (fr) * 2017-12-01 2019-06-05 Samsung Electronics Co., Ltd. Appareil et procédé d'évaluation de la qualité de signaux biologiques
EP3494895A1 (fr) * 2017-12-07 2019-06-12 Koninklijke Philips N.V. Surveillance de patient
WO2019110430A1 (fr) * 2017-12-07 2019-06-13 Koninklijke Philips N.V. Surveillance de patient
US11399809B2 (en) 2017-12-07 2022-08-02 Koninklijke Philips N.V. Patient monitoring
US11896421B2 (en) * 2018-02-08 2024-02-13 Koninklijke Philips N.V. Monitoring blood distribution in a subject
CN111818854B (zh) * 2018-02-08 2025-02-11 皇家飞利浦有限公司 监测对象中的血液分布
US20210085280A1 (en) * 2018-02-08 2021-03-25 Koninklijke Philips N.V. Monitoring blood distribution in a subject
CN111818854A (zh) * 2018-02-08 2020-10-23 皇家飞利浦有限公司 监测对象中的血液分布
US12178581B2 (en) 2019-04-17 2024-12-31 Masimo Corporation Patient monitoring systems, devices, and methods
US11986305B2 (en) 2019-04-17 2024-05-21 Masimo Corporation Liquid inhibiting air intake for blood pressure monitor
US12390140B2 (en) 2019-04-17 2025-08-19 Masimo Corporation Blood pressure cuff
US12433524B2 (en) 2019-04-17 2025-10-07 Masimo Corporation Electrocardiogram device
US11637437B2 (en) 2019-04-17 2023-04-25 Masimo Corporation Charging station for physiological monitoring device
US11701043B2 (en) 2019-04-17 2023-07-18 Masimo Corporation Blood pressure monitor attachment assembly
US11678829B2 (en) 2019-04-17 2023-06-20 Masimo Corporation Physiological monitoring device attachment assembly
USD1037462S1 (en) 2019-08-16 2024-07-30 Masimo Corporation Holder for a patient monitor
USD919100S1 (en) 2019-08-16 2021-05-11 Masimo Corporation Holder for a patient monitor
USD917704S1 (en) 2019-08-16 2021-04-27 Masimo Corporation Patient monitor
USD967433S1 (en) 2019-08-16 2022-10-18 Masimo Corporation Patient monitor
USD985498S1 (en) 2019-08-16 2023-05-09 Masimo Corporation Connector
USD933234S1 (en) 2019-08-16 2021-10-12 Masimo Corporation Patient monitor
USD919094S1 (en) 2019-08-16 2021-05-11 Masimo Corporation Blood pressure device
USD933233S1 (en) 2019-08-16 2021-10-12 Masimo Corporation Blood pressure device
USD921202S1 (en) 2019-08-16 2021-06-01 Masimo Corporation Holder for a blood pressure device
USD1066672S1 (en) 2019-08-16 2025-03-11 Masimo Corporation Patient monitor and holder
USD950738S1 (en) 2019-10-18 2022-05-03 Masimo Corporation Electrode pad
USD927699S1 (en) 2019-10-18 2021-08-10 Masimo Corporation Electrode pad
USD965789S1 (en) 2020-05-11 2022-10-04 Masimo Corporation Blood pressure monitor
USD1060680S1 (en) 2020-05-11 2025-02-04 Masimo Corporation Blood pressure monitor
USD933232S1 (en) 2020-05-11 2021-10-12 Masimo Corporation Blood pressure monitor
USD979516S1 (en) 2020-05-11 2023-02-28 Masimo Corporation Connector

Similar Documents

Publication Publication Date Title
WO2017093150A1 (fr) Appareil de surveillance et procédé de surveillance pour déterminer des informations de signes vitaux d'un sujet
CN107920760B (zh) 用于监测对象的血压的监测装置
US12303242B2 (en) Optical vital signs sensor
AU2018210232B2 (en) Non-invasive blood pressure measurement using pulse wave velocity
CN108024790B (zh) 用于对对象进行医学检查的超声装置和方法
JP6573988B2 (ja) 血流速度を決定する装置及び方法
US11406273B2 (en) Continuous blood pressure measurement
JP6508325B2 (ja) 血管内の血圧を求める方法、並びに、該方法を実行する装置
CN105708431A (zh) 血压实时测量装置及测量方法
CN105163662A (zh) 用于测量静脉血氧的方法和装置
US11723543B2 (en) Non-invasive system and method for measuring blood pressure variability
EP4422482B1 (fr) Dispositif, système et procédé d'étalonnage d'un substitut de pression sanguine pour une utilisation dans la surveillance de la pression sanguine d'un sujet
US20250221628A1 (en) Device, system and method for calibrating a blood pressure surrogate for use in monitoring a subject's blood pressure
WO2019053276A1 (fr) Dispositif de détermination de la pression artérielle diastolique d'un sujet
JP4680411B2 (ja) 動脈血圧測定方法および動脈血圧測定装置
KR20200129811A (ko) 혈압 측정 시스템 및 이를 이용한 혈압 측정 방법
KR20200043900A (ko) 혈압계 및 이를 이용한 혈압 측정 방법
US20140243691A1 (en) Measurement device, index calculating method, and index calculating program
JP2018130227A (ja) 血管脈波測定システム
WO2025129147A1 (fr) Système de surveillance de patient utilisant des ultrasons et une bio-impédance
EP3456254A1 (fr) Dispositif pour déterminer la pression sanguine diastolique d'un sujet
KR20220153790A (ko) 혈압 측정 시스템 및 이를 이용한 혈압 측정 방법
CN109222923A (zh) 一种头颈部动脉脉搏波传感器检测系统

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 16801510

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 16801510

Country of ref document: EP

Kind code of ref document: A1